ストックスクリーナーアプリを入手
6.47
0.31%
-0.02
前日終値:
$6.49
開ける：
$6.49
24時間の取引高:
8,227
Relative Volume:
0.76
時価総額：
$464.94M
収益：
$510.62M
当期純損益:
$110.37M
株価収益率:
6.883
EPS:
0.94
ネットキャッシュフロー:
$423.23M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$5.73
$8.75
Sinovac Biotech, Ltd Stock (SVA) Company Profile
名前
Sinovac Biotech, Ltd
セクター
産業
電話
-
住所
-
Compare SVA vs
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SVA
Sinovac Biotech, Ltd
|
6.47 | 464.94M | 510.62M | 110.37M | 423.23M | 0.94 |
Sinovac Biotech, Ltd (SVA) 最新ニュース
Licensable picture: A technician puts a bottle of H1N1 flu virus into a transfer cabinet during preparations to produce vaccines for the flu virus at a lab in Wuhan - reutersconnect.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its OfficersSVA - TMX Newsfile
Licensable picture: Technician works in inoculation area of Sinovac Biotech Ltd. during production of a vaccine for the H1N1 flu virus in Beijing - reutersconnect.com
Sinovac Biotech Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
1Globe Capital Deadline Alert - TMX Newsfile
Sinovac Biotech, Ltd. Revenue Breakdown – NASDAQ:SVA - TradingView
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend - Via TT
Price to book forward of Sinovac Biotech, Ltd. – NASDAQ:SVA - TradingView
Sinovac Biotech LtdADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Sinovac Biotech LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Enterprise value to EBIT forward of Sinovac Biotech, Ltd. – NASDAQ:SVA - TradingView
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements - Via TT
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements - STT Info
Sinovac faces delisting after missing 2025 annual report filing - Investing.com
Chancery Sends Sinovac Biotech Suit To Antigua And Barbuda - Law360
Sinovac Controlling Shareholders Escape Investor Disclosure Suit - Bloomberg Law News
Sinovac Wins Nasdaq Reprieve as Governance Fight Drags On - Caixin Global
Sinovac's inactivated hepatitis A vaccine wins contract in Oman - China Daily
Chinese firm Sinovac to supply vaccine to Chile ahead of flu season - scmp.com
Sinovac receives second Nasdaq non-compliance notice - Investing.com
Antigua court sets Sinovac board until 2026 trial over disputed meeting - Investing.com
Sinovac faces Nasdaq delisting over delayed annual report filing - Investing.com
Sinovac expands flu vaccine age range to 6 months and older - China Daily
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment - Yahoo Finance
Sinovac shareholders push for payment of declared $19 dividend - Investing.com
BreakingviewsCOMMENTARY: Biotech nears cure for Chinese corporate epidemic - Reuters
Sinovac Biotech, Ltd (SVA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):